We have licensed certain proprietary intellectual property to Unbuzzd and Celly U.S. pursuant to an Amended and Restated Exclusive License Agreement, dated as of August 14, 2024
We have licensed certain proprietary intellectual property to Unbuzzd and Celly U.S. pursuant to an Amended and Restated Exclusive License Agreement, dated as of August 14, 2024
ed on December 5, 2024 (the “December 5 NR”) as amended on January 20, 2025, and based on the better terms announced on March 7, 2025 (the “March 7 NR”). The Company issued 2,420 Debenture Units (as …
is Pharma Inc. (“ Corealis ”), Adgyl Lifesciences (“ Adgyl ”) and Vibrant Pharma Inc. (“ Vibrant Pharma ”). Each of Ingenu, BioPharma, Erythro, Corealis, Adgyl and Vibrant Pharma are CROs that, in th…
may have resulted, and may continue to result, in speculation regarding future appreciation in the value of cryptocurrencies, inflating their market prices and making those market prices more volatil…
Reciprocal relationship from FIISP graph: Reciprocal relationship from QNTM graph: Reciprocal relationship from FIISP graph: Reciprocal relationship from QNTM graph: may have resulted, and may contin…
Quantum BioPharma Ltd. Debt Obligations
Instrument
Description
Confidence
Evidence
QNTM-DEBT
Debt stack $870,057
90%
Market cache reports total debt of $870,057.
Quantum BioPharma Ltd. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Quantum BioPharma Ltd..
Quantum BioPharma Ltd. Ownership
Holder
Name
Confidence
Evidence
QNTM-OWNER-ADVISORSHARES-INVESTMENTS-LLC
AdvisorShares Investments LLC
90%
13F overlay lists AdvisorShares Investments LLC as top holder; 26 tracked holders.
